A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Paola Guglielmelli Lisa Pieri Srdan Verstovsek Tiziano Barbui Francesco Passamonti Alessandro Rambaldi |
| Publication date | February 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |